New hope for lung cancer patients: radiation plus drugs may extend life

NCT ID NCT06141070

NEW Recruiting now Disease control Sponsor: Vastra Gotaland Region Source: ClinicalTrials.gov ↗

First seen Apr 28, 2026 · Last updated Apr 28, 2026

Summary

This study tests whether adding high-dose radiation to standard drug therapy (chemotherapy or immunotherapy) improves survival in people with non-small cell lung cancer that has spread to up to 5 spots. About 240 participants will be randomly assigned to receive either standard treatment alone or standard treatment plus radiation to all known tumors. The goal is to see if the combination helps people live longer and delays cancer growth.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Dept of Oncology
RECRUITING

Gothenburg, 41345, Sweden

Contact Email: •••••@•••••
Dept of Oncology
RECRUITING

Stockholm, Sweden

Contact Email: •••••@•••••
Dept of pulmonary medicine
NOT_YET_RECRUITING

Linköping, Sweden

Contact Email: •••••@•••••
Dept of pulmonary medicine
NOT_YET_RECRUITING

Lund, Sweden

Contact Email: •••••@•••••
Dept. of Oncology
RECRUITING

Umeå, Sweden

Contact Email: •••••@•••••
Dept. of Oncology
RECRUITING

Uppsala, Sweden

Contact Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

NON-SMALL CELL LUNG CANCER